BMJ examined the FDA's flawed safety system, involving the FDA and Control Data Corporation.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• BMJ →

  global healthcare knowledge provider, wholly owned subsidiary of the British Medical Association

  Nothing else this week.

• Control Data Corporation →

  defunct supercomputer firm

  • The Securities and Exchange Commission (SECP) guides the digital initiative of Control Data Corporation (CDCPL), which operates within the Pakistani market. Sidhu chaired the relevant meeting.Sun 11:40
  • Jacobs is the union president for Control Data Corporation (CDC) workers in Atlanta.Sun 02:36

Related events

• The FDA is accused of failing to enforce safety regulations and operating under current rules without in-person oversight.Aug 27
• The FDA is facing public scrutiny due to oversight failures, leading to the introduction of new legislation targeting agency shortcomings.Sep 22
• FDA reviewed protocol amendment and interim safety data for a company's product.Jun 24
• FDA guidance is driving the need for a safety assessment related to issues in Rockville.Aug 19
• FDA safety warnings have been issued, causing caution among clinicians.Jun 21